학술논문

Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Document Type
Article
Source
In: Biology of Blood and Marrow Transplantation. (Biology of Blood and Marrow Transplantation, February 2020, 26(2):262-271)
Subject
Language
English
ISSN
15236536
10838791